☆ 4.6 Review

Engineered multifunctional nanocarriers for controlled drug delivery in tumor immunotherapy

FRONTIERS IN ONCOLOGY (2022)

Related references

Note: Only part of the references are listed.
Article Chemistry, Multidisciplinary

Evolution of drug delivery systems: From 1950 to 2020 and beyond

Haesun Park et al.

Summary: The advancement in modern drug delivery technology over the past seven decades has revolutionized the field, providing innovative solutions to current and future unmet needs in disease treatment. These technological advancements are essential in overcoming challenges faced today and in developing more efficient formulations for long-term care.

JOURNAL OF CONTROLLED RELEASE (2022)

Add to Collection
Review Biochemistry & Molecular Biology

Phenotypic heterogeneity, stability and plasticity in tumor-promoting carcinoma-associated fibroblasts

Yoshihiro Mezawa et al.

Summary: The reciprocal interactions between cancer cells and stromal cells in the tumor microenvironment are crucial for tumor development. Carcinoma-associated fibroblasts (CAFs) play a key role in the TME and are composed of distinct fibroblast populations, showing intratumor heterogeneity and impacting tumor growth, metastasis, and therapeutic responses.

FEBS JOURNAL (2022)

Add to Collection
Review Immunology

Nanodrugs Targeting T Cells in Tumor Therapy

Maximilian Haist et al.

Summary: In contrast to conventional anti-tumor agents, nano-carriers allow co-delivery of distinct drugs in a cell type-specific manner. This review summarizes the strategies of nanodrug-based approaches to address and reprogram Treg to overcome their immunomodulatory activity and to revert the exhaustive state of T effector cells.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection
Review Oncology

Nano Drug Delivery System for Tumor Immunotherapy: Next-Generation Therapeutics

Lili Zhou et al.

Summary: Tumor immunotherapy is a powerful strategy for treating cancer by stimulating the immune system. However, the heterogeneity of tumors and immunosuppressive microenvironment make it difficult for immunotherapy to be effective. With the advancements in materials science and nanotechnology, innovative biomaterials and drug delivery systems can enhance the effectiveness of immunotherapy.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection
Review Pharmacology & Pharmacy

Bioinspired and Biomimetic Nanomedicines for Targeted Cancer Therapy

Xiaoqiu Xu et al.

Summary: Nanomedicines offer alternative strategies for tumor-targeted therapy due to their nanoscale size and tunable surface features. Biomimetic nanomedicines show promising potential in maximizing anti-tumor efficacy with minimal adverse effects due to their good biocompatibility and high accumulation abilities.

PHARMACEUTICS (2022)

Add to Collection
Review Pharmacology & Pharmacy

Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials

Syed Nasir Abbas Bukhari

Summary: A key issue in modern cancer treatment is the resistance to conventional chemotherapy and targeted medicines. Cancer nanotherapeutics aim to overcome these limitations and provide effective treatment through the use of nanoparticulate delivery systems. Various strategies such as passive and active targeting, nano-drug, and combination therapy have shown promising results. However, the complexity of tumor biology and limited understanding of nano-bio interactions hinder the clinical translation and commercialization of cancer nanotherapeutics.

PHARMACEUTICS (2022)

Add to Collection
Review Chemistry, Multidisciplinary

Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics

Neda Khosravi et al.

Summary: Nanomedicine research has made significant progress, but encounters obstacles such as low drug concentration and rapid drug elimination. Stem cell membranes and stem cell-derived exosomes have emerged as promising therapeutic carriers. Combining synthetic nanoparticles with stem cell membranes enhances drug delivery. Utilizing stem cell-derived exosome membranes improves the therapeutic capability of engineered drug delivery vehicles.

JOURNAL OF CONTROLLED RELEASE (2022)

Add to Collection
Article Oncology

Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy

Sibi Raj et al.

Summary: Nanotechnology offers a promising approach for cancer diagnosis and treatment, providing specific and efficient drug delivery to target tissues while minimizing side effects. Various types of nanocarriers are being studied for potential use in cancer therapy.

SEMINARS IN CANCER BIOLOGY (2021)

Add to Collection
Review Chemistry, Multidisciplinary

Carrier-free nanodrugs for safe and effective cancer treatment

Sena Karaosmanoglu et al.

Summary: The clinical applications of many anti-cancer drugs are limited by their hydrophobic nature, leading to the development of carrier-based nanoparticles. However, these strategies often fail to efficiently encapsulate drugs and may cause toxicity problems in the long term. Therefore, elegantly designed strategies for carrier-free nanodrugs, including simple self-assembly and chemical modifications, are desired for high quality, stability, and performance.

JOURNAL OF CONTROLLED RELEASE (2021)

Add to Collection
Article Engineering, Biomedical

Advances and perspectives in carrier-free nanodrugs for cancer chemo-monotherapy and combination therapy

Li Huang et al.

Summary: Carrier-free nanodrugs, completely formulated with one or more drugs, have shown great potential in cancer therapy by improving pharmacodynamics/pharmacokinetics, reducing toxicity, and increasing drug loading. Utilizing different preparation strategies, these nanodrugs have demonstrated advantages in various therapeutic modalities, which may pave the way for effective treatments in the future.

BIOMATERIALS (2021)

Add to Collection
Review Engineering, Biomedical

Targeting nanoparticles for diagnosis and therapy of bone tumors: Opportunities and challenges

Xin Gao et al.

Summary: This review focuses on the principles and methods in the design of targeted nanoparticles for the diagnosis and therapy of orthotopic and metastatic bone tumors. Various ligands have been grafted on nanoparticles for bone targeting, and different targeting strategies using monoclonal antibodies, peptides, and aptamers have been explored for diagnosis and therapy. The development of multifunctional nanoparticles to disrupt the vicious cycle between tumor cell proliferation and bone resorption, as well as the challenges and perspectives in this area, are also discussed.

BIOMATERIALS (2021)

Add to Collection
Article Chemistry, Physical

Self-targeting visualizable hyaluronate nanogel for synchronized intracellular release of doxorubicin and cisplatin in combating multidrug-resistant breast cancer

Wen Ma et al.

Summary: In this study, a self-targeting hyaluronate nanogel was developed for reversing drug resistance through synchronized pharmacokinetics, intratumoral distribution, and intracellular release of doxorubicin and cisplatin. This nanogel showed efficient drug delivery into drug-resistant breast cancer cells and enhanced antitumor activity, with potential for future clinical therapy of advanced cancers. Visualized synchronized drug delivery and imaging techniques facilitate the visualization of combination tumor chemotherapy.

NANO RESEARCH (2021)

Add to Collection
Article Nanoscience & Nanotechnology

A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells

Shiyang Shen et al.

Summary: This study presents a nanoparticle-based strategy for killing CSCs in tumors by inducing CSC differentiation with all-trans retinoic acid release under hypoxic conditions and triggering cell death with camptothecin release in response to increasing reactive oxygen species levels in differentiating CSCs.

NATURE NANOTECHNOLOGY (2021)

Add to Collection
Article Nanoscience & Nanotechnology

Considerations for designing preclinical cancer immune nanomedicine studies

Wen Jiang et al.

Summary: Cancer immune nanomedicine faces complexities and challenges in practice, requiring researchers to consider factors such as tumor response complexity and immunotherapy comprehensively. Researchers need to delve into the internal and external influencing factors of tumors to better design experiments in cancer immune nanomedicine.

NATURE NANOTECHNOLOGY (2021)

Add to Collection
Article Chemistry, Multidisciplinary

Multifunctional nanoreactors-integrated microneedles for cascade reaction-enhanced cancer therapy

Yixian Zhou et al.

Summary: A strategy of cascade reaction-enhanced combined therapy based on oxygen-evolving multifunctional nanoreactors is proposed for tumor therapy. Immobilizing GOx and CAT in metal-organic frameworks via biomimetic mineralization enhances enzyme stability and improves efficacy in tumor treatment. The nanoreactors, delivered by microneedles, achieve efficient tumor accumulation and strengthen antitumor efficacy without obvious side effects.

JOURNAL OF CONTROLLED RELEASE (2021)

Add to Collection
Article Chemistry, Multidisciplinary

Recent advances in microneedles-based drug delivery device in the diagnosis and treatment of cancer

Vanshikha Singh et al.

Summary: Microneedles are a unique and effective method for delivering therapeutic drugs and immunobiologicals, designed to penetrate deep into the skin for targeted drug delivery. They offer a painless and self-administrative alternative to traditional routes of drug delivery and show potential for use in cancer therapy, early diagnosis, and combined treatments with other therapies. These tiny needle patches can be fabricated and altered to suit different needs, offering a versatile and promising approach in the field of drug delivery and cancer therapy.

JOURNAL OF CONTROLLED RELEASE (2021)

Add to Collection
Review Biochemistry & Molecular Biology

Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives

Xiaoqi Mao et al.

Summary: CAFs, as a crucial component of TME, play significant roles in promoting tumor growth, invasion, and metastasis. The interaction between CAFs and tumor cells, as well as immune cells in TIME, is critical for tumor progression.

MOLECULAR CANCER (2021)

Add to Collection
Review Biochemistry & Molecular Biology

Controlled Drug Delivery Systems: Current Status and Future Directions

Shivakalyani Adepu et al.

Summary: The paper discusses the evolution of drug delivery systems, the limitations of conventional drug delivery, and the details of controlled drug delivery systems, including design considerations, classifications, and recent research findings on nano-drug delivery, targeted drug delivery, and smart drug delivery using intelligent biomaterials. The challenges and future directions in controlled drug delivery are also addressed in the conclusion.

MOLECULES (2021)

Add to Collection
Article Chemistry, Multidisciplinary

Microneedles for painless transdermal immunotherapeutic applications

Hamed Amani et al.

Summary: Immunotherapy using microneedles shows promising potential in enhancing immune responses and improving treatment outcomes for various diseases, with the advantage of minimal invasiveness and direct translocation of therapeutics into systemic circulation.

JOURNAL OF CONTROLLED RELEASE (2021)

Add to Collection
Review Chemistry, Multidisciplinary

Nanomedicines accessible in the market for clinical interventions

Vedant Gadekar et al.

Summary: Nanomedicines, also known as nano-pharmaceuticals, have shown great potential in improving therapeutic efficacy and reducing side effects. Despite a considerable market share, challenges such as safety, regulatory hurdles, and cost need to be addressed for their market entry. This review discusses the current market status, challenges, and potential of nanomedicines.

JOURNAL OF CONTROLLED RELEASE (2021)

Add to Collection
Article Chemistry, Multidisciplinary

Nano-immunotherapy: Unique mechanisms of nanomaterials in synergizing cancer immunotherapy

Quan Liu et al.

Summary: Therapeutic targeting of the immune system, including immunotherapy and nanotechnology, presents a promising approach for treating various cancers. While immunotherapeutics have limitations, nanotechnology offers unique opportunities to enhance therapeutic efficacy through precision targeting and controlled drug release. Combining these two modalities could provide synergistic efficacy in cancer treatment.

NANO TODAY (2021)

Add to Collection
Article Oncology

Targeting the tumour microenvironment in platinum-resistant ovarian cancer

M. Cummings et al.

Summary: Ovarian cancer often presents at an advanced stage and initial response to platinum-based therapies is positive, but chemoresistance develops leading to poor prognosis. The tumor microenvironment has been found to play a central role in therapy resistance and disease progression, making it an attractive therapeutic target. Focus has been on targeting cancer associated fibroblasts, tumor-associated macrophages, cancer stem cells, and cancer cell metabolic vulnerabilities for new therapies.

SEMINARS IN CANCER BIOLOGY (2021)

Add to Collection
Review Chemistry, Multidisciplinary

Glutathione-Depleting Nanomedicines for Synergistic Cancer Therapy

Xiaotong Cheng et al.

Summary: Overexpression of glutathione in cancer cells leads to resistance to anticancer therapies, making GSH depletion a potential target for cancer treatments. By combining with mainstream cancer therapies, GSH-depleting agents can enhance cancer cells responses to cell death stimuli.

ACS NANO (2021)

Add to Collection
Review Pharmacology & Pharmacy

RNA-Based Therapeutics: Current Developments in Targeted Molecular Therapy of Triple-Negative Breast Cancer

Sakib Haque et al.

Summary: Triple-negative breast cancer is a highly heterogeneous and aggressive cancer subtype with the highest mortality rate. Conventional treatments have been unsuccessful, leading to research efforts in developing new strategies. Targeted molecular therapy and RNA-based therapeutics are key areas of investigation for treating TNBC.

PHARMACEUTICS (2021)

Add to Collection
Review Pharmacology & Pharmacy

Smart Nanotherapeutics and Lung Cancer

Mohammad Doroudian et al.

Summary: Lung cancer is a significant global health issue, and current therapeutic strategies need to improve specificity and reduce side effects. Nanotechnology can enhance treatment efficiency, and advanced nanotechnology strategies are being used to overcome challenges in lung cancer treatments.

PHARMACEUTICS (2021)

Add to Collection
Article Chemistry, Multidisciplinary

X-ray-responsive polypeptide nanogel for concurrent chemoradiotherapy

Juan Wang et al.

Summary: An X-ray-responsive polypeptide nanogel was developed for on-demand delivery of chemotherapeutic agent triggered by radiotherapy to synergistically improve the efficacy of CCRT with reduced side effects. This smart nanogel provides a promising bridge between chemotherapy and radiotherapy, enhancing the potential application of CCRT in clinic.

JOURNAL OF CONTROLLED RELEASE (2021)

Add to Collection
Article Engineering, Biomedical

Conjugation of glucosylated polymer chains to checkpoint blockade antibodies augments their efficacy and specificity for glioblastoma

Tao Yang et al.

Summary: Monoclonal antibodies conjugated with multiple polymer chains, functionalized to target glucose transporter 1 and detaching in the reductive tumor microenvironment, can enhance the potency and safety of checkpoint blockade therapy for glioblastoma. This approach showed promising results in mouse models, reinvigorating antitumor immune responses and inducing protective immunological memory against tumor rechallenge.

NATURE BIOMEDICAL ENGINEERING (2021)

Add to Collection
Article Chemistry, Multidisciplinary

Microtubule-Targeted Self-Assembly Triggers Prometaphase-Metaphase Oscillations Suppressing Tumor Growth

Guanying Li et al.

Summary: By synthesizing peptide-based rotor molecules with the potential to self-assemble, researchers were able to target microtubules and inhibit cancer cell proliferation without inducing obvious neurotoxicity, showcasing a novel approach for cancer therapy.

NANO LETTERS (2021)

Add to Collection
Article Chemistry, Multidisciplinary

Engineering Endogenous Tumor-Associated Macrophage-Targeted Biomimetic Nano-RBC to Reprogram Tumor Immunosuppressive Microenvironment for Enhanced Chemo-Immunotherapy

Yupeng Wang et al.

Summary: An engineered biomimetic nano-RBC system utilizing hemoglobin is developed to deliver chemotherapy drugs and oxygen, effectively reprogramming the tumor immunosuppressive microenvironment. This strategy targets tumor-associated macrophages and alleviates tumor hypoxia, enhancing the antitumor immune response and inhibiting tumor metastasis and recurrence.

ADVANCED MATERIALS (2021)

Add to Collection
Review Pharmacology & Pharmacy

Novel nanomedicines to overcome cancer multidrug resistance

Zhenwei Su et al.

Summary: Chemotherapy is powerful in eliminating malignant cells, but its efficacy is often hindered by drug resistance. Nanomedicine, focusing on targeted drug delivery to tumor tissues using nano-sized formulations, shows promise in improving treatment outcomes, minimizing adverse effects, and overcoming cancer drug resistance. This approach involves strategies such as passive and active targeted delivery, delivering multidrug combinations, and multimodal combination therapy to pave the way for effective cancer treatment and holds great potential in overcoming drug resistance.

DRUG RESISTANCE UPDATES (2021)

Add to Collection
Review Nanoscience & Nanotechnology

Nanomaterials-Based Photodynamic Therapy with Combined Treatment Improves Antitumor Efficacy Through Boosting Immunogenic Cell Death

Feiyang Jin et al.

Summary: With the rapid development of nanotechnology, photodynamic therapy is emerging as a novel non-invasive clinical treatment for specific cancers. Although induced cell death related to T cell-mediated antitumor immune responses through immunogenic cell death is promising, enhancing this immunogenic cell death for better efficacy remains a challenge.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)

Add to Collection
Article Nanoscience & Nanotechnology

Surface-fill hydrogel attenuates the oncogenic signature of complex anatomical surface cancer in a single application

Poulami Majumder et al.

Summary: The authors engineered a peptide-based surface-fill hydrogel (SFH) that can be applied to surface cancers during surgery to effectively reduce the risk of tumor recurrence post-surgery.

NATURE NANOTECHNOLOGY (2021)

Add to Collection
Review Oncology

Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment

Miriam Gaggianesi et al.

Summary: Despite advances in cancer patient management and targeted therapies, systemic chemotherapy remains the first-line treatment for many cancer types. Resistance to chemotherapeutic regimens is attributed to a subpopulation of cancer cells known as cancer stem cells (CSCs) within the tumor mass. Tumor microenvironment (TME) components such as adipocytes, cancer-associated fibroblasts (CAFs), immune cells, and endothelial cells contribute to CSC chemoresistance through the release of growth factors and cytokines.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection
Review Pharmacology & Pharmacy

Advances in Cancer Therapeutics: Conventional Thermal Therapy to Nanotechnology-Based Photothermal Therapy

Sangeeta Kumari et al.

Summary: This review highlights the transition from traditional thermal therapies to laser-based photothermal therapies in cancer treatment, emphasizing the role of nanoparticles as photothermal agents. Studies have shown promising outcomes of photothermal therapy in both in vitro and in vivo settings, as well as in recent clinical studies.

PHARMACEUTICS (2021)

Add to Collection
Review Nanoscience & Nanotechnology

Recent Advances in Nanomaterials Development for Nanomedicine and Cancer

Abolghasem Abbasi Kajani et al.

Summary: Nanomedicine has offered a promising approach to addressing the challenges in cancer detection and treatment, with a wide range of engineered nanomaterials being developed for biomedical applications including bioimaging, diagnosis, and therapy for cancers.

ACS APPLIED BIO MATERIALS (2021)

Add to Collection
Review Biochemistry & Molecular Biology

Emerging Significance and Therapeutic Potential of Extracellular vesicles

Ruhua Luo et al.

Summary: EVs are membrane-bound vesicles that offer advantages over traditional nanocarriers for drug and gene delivery, with therapeutic potential through chemical or biological modifications. Modified EVs can be used to load various therapeutic agents for disease intervention, providing new avenues for effective treatment strategies.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Add to Collection
Article Chemistry, Multidisciplinary

Dissolving microneedles delivering cancer cell membrane coated nanoparticles for cancer immunotherapy

Wonchan Park et al.

Summary: A study developed a method to deliver drugs to the skin through microneedles, stimulating the immune system using tumor cell membrane proteins as specific antigens and a TLR7 agonist to inhibit cancer cell growth. In vivo experiments showed that microneedles loaded with F127-R837@M NPs significantly inhibited cancer cell growth.

RSC ADVANCES (2021)

Add to Collection
Review Endocrinology & Metabolism

Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism

Ilaria Elia et al.

Summary: The article provides a detailed examination of the complexity of cellular metabolism within the tumor microenvironment, along with potential therapeutic intervention opportunities. Cancer cell metabolism and behavior are regulated by multiple factors, and the metabolic environment within the TME is influenced by various tiers. Understanding the interactions of these tiers reveals unique therapeutic potential for modulating the metabolic profile and function of all cells in the TME.

NATURE METABOLISM (2021)

Add to Collection
Review Oncology

Insights into new mechanisms and models of cancer stem cell multidrug resistance

Y. Garcia-Mayea et al.

SEMINARS IN CANCER BIOLOGY (2020)

Add to Collection
Article Engineering, Biomedical

The novel platinum(IV) prodrug with self-assembly property and structure transformable character against triple-negative breast cancer

Conglian Yang et al.

BIOMATERIALS (2020)

Add to Collection
Review Oncology

A review of cancer immunotherapy toxicity

Lucy Boyce Kennedy et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Add to Collection
Review Medicine, Research & Experimental

Hydrogel-Based Controlled Drug Delivery for Cancer Treatment: A Review

Zhaoyi Sun et al.

MOLECULAR PHARMACEUTICS (2020)

Add to Collection
Review Multidisciplinary Sciences

The biology, function, and biomedical applications of exosomes

Raghu Kalluri et al.

SCIENCE (2020)

Add to Collection
Review Engineering, Biomedical

Self-assembling prodrug nanotherapeutics for synergistic tumor targeted drug delivery

Zhiren Wang et al.

ACTA BIOMATERIALIA (2020)

Add to Collection
Article Biotechnology & Applied Microbiology

Breaking the selectivity-uptake trade-off of photoimmunoconjugates with nanoliposomal irinotecan for synergistic multi-tier cancer targeting

Barry J. Liang et al.

JOURNAL OF NANOBIOTECHNOLOGY (2020)

Add to Collection
Review Oncology

Molecular avenues in targeted doxorubicin cancer therapy

Sayantani Roychoudhury et al.

FUTURE ONCOLOGY (2020)

Add to Collection
Article Chemistry, Multidisciplinary

Translational Nanomedicine Boosts Anti-PD1 Therapy to Eradicate Orthotopic PTEN-Negative Glioblastoma

Hiroaki Kinoh et al.

ACS NANO (2020)

Add to Collection
Review Medicine, Research & Experimental

Exosomes as drug carriers for cancer therapy and challenges regarding exosome uptake

Xiaoyin Zhao et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Add to Collection
Review Chemistry, Multidisciplinary

Tumor microenvironment-induced structure changing drug/gene delivery system for overcoming delivery -associated challenges

Min Zhang et al.

JOURNAL OF CONTROLLED RELEASE (2020)

Add to Collection
Review Chemistry, Multidisciplinary

Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies

Farshad Moradi Kashkooli et al.

JOURNAL OF CONTROLLED RELEASE (2020)

Add to Collection
Article Engineering, Biomedical

Effective treatment of drug-resistant lung cancer via a nanogel capable of reactivating cisplatin and enhancing early apoptosis

Min Sun et al.

BIOMATERIALS (2020)

Add to Collection
Review Oncology

Clinical development and potential of photothermal and photodynamic therapies for cancer

Xingshu Li et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

Add to Collection
Article Nanoscience & Nanotechnology

Pathological Mechanism of Photodynamic Therapy and Photothermal Therapy Based on Nanoparticles

Yun-jing Hou et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)

Add to Collection
Review Nanoscience & Nanotechnology

Cancer-Derived Exosomes: Their Role in Cancer Biology and Biomarker Development

Victor C. Kok et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)

Add to Collection
Review Chemistry, Multidisciplinary

Surface functionalization of exosomes for target-specific delivery and in vivo imaging & tracking: Strategies and significance

Shubham Salunkhe et al.

JOURNAL OF CONTROLLED RELEASE (2020)

Add to Collection
Article Chemistry, Multidisciplinary

Controlled drug delivery with nanoassemblies of redox-responsive prodrug and polyprodrug amphiphiles

Zhengyu Deng et al.

JOURNAL OF CONTROLLED RELEASE (2020)

Add to Collection
Article Cell Biology

Bone marrow mesenchymal stem cells-derived exosomal microRNA-193a reduces cisplatin resistance of non-small cell lung cancer cells via targeting LRRC1

Hongbo Wu et al.

CELL DEATH & DISEASE (2020)

Add to Collection
Review Pharmacology & Pharmacy

Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy

Yuefei Zhu et al.

ACTA PHARMACEUTICA SINICA B (2020)

Add to Collection
Review Immunology

Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy

Wei Li et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection
Review Pharmacology & Pharmacy

Microneedles Drug Delivery Systems for Treatment of Cancer: A Recent Update

Aravindram Attiguppe Seetharam et al.

PHARMACEUTICS (2020)

Add to Collection
Article Multidisciplinary Sciences

Trisulfide bond-mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity

Yinxian Yang et al.

SCIENCE ADVANCES (2020)

Add to Collection
Article Chemistry, Multidisciplinary

Microneedles loaded with anti-PD-1-cisplatin nanoparticles for synergistic cancer immuno-chemotherapy

Xinmiao Lan et al.

NANOSCALE (2020)

Add to Collection
Review Medicine, Research & Experimental

Imaging-assisted anticancer nanotherapy

Anshuman Dasgupta et al.

THERANOSTICS (2020)

Add to Collection
Review Medicine, Research & Experimental

RNA Nanotechnology-Mediated Cancer Immunotherapy

Yao-Xin Lin et al.

THERANOSTICS (2020)

Add to Collection
Review Oncology

Tumour Cell Secretome in Chemoresistance and Tumour Recurrence

Emma C. Madden et al.

TRENDS IN CANCER (2020)

Add to Collection
Review Chemistry, Multidisciplinary

Advances in PEG-based ABC terpolymers and their applications

Xiaojin Zhang et al.

RSC ADVANCES (2020)

Add to Collection
Article Chemistry, Multidisciplinary

Dual photothermal MDSCs-targeted immunotherapy inhibits lung immunosuppressive metastasis by enhancing T-cell recruitment

Kattiopi Domvri et al.

NANOSCALE (2020)

Add to Collection
Review Oncology

Exosomes play roles in sequential processes of tumor metastasis

Keyu Li et al.

INTERNATIONAL JOURNAL OF CANCER (2019)

Add to Collection
Article Medicine, Research & Experimental

Antigen delivery targeted to tumor-associated macrophages overcomes tumor immune resistance

Daisuke Muraoka et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Add to Collection
Review Biochemistry & Molecular Biology

Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance

Ladan Mashouri et al.

MOLECULAR CANCER (2019)

Add to Collection
Review Biochemistry & Molecular Biology

Exosome-orchestrated hypoxic tumor microenvironment

Wanrong Meng et al.

MOLECULAR CANCER (2019)

Add to Collection
Article Nanoscience & Nanotechnology

Tumor-Targeting, MicroRNA-Silencing Porous Silicon Nanoparticles for Ovarian Cancer Therapy

Alessandro Bertucci et al.

ACS APPLIED MATERIALS & INTERFACES (2019)

Add to Collection
Review Nanoscience & Nanotechnology

Top-down fabrication-based nano/microparticles for molecular imaging and drug delivery

Susmita Aryal et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)

Add to Collection
Review Chemistry, Multidisciplinary

Nanogels for regenerative medicine

Maria Aurora Grimaudo et al.

JOURNAL OF CONTROLLED RELEASE (2019)

Add to Collection
Review Chemistry, Multidisciplinary

MicroRNA delivery through nanoparticles

Sharon Wei Ling Lee et al.

JOURNAL OF CONTROLLED RELEASE (2019)

Add to Collection
Review Multidisciplinary Sciences

A view on drug resistance in cancer

Neil Vasan et al.

NATURE (2019)

Add to Collection
Article Chemistry, Multidisciplinary

A Paclitaxel-Based Mucoadhesive Nanogel with Multivalent Interactions for Cervical Cancer Therapy

Qiuhui Qian et al.

SMALL (2019)

Add to Collection
Article Multidisciplinary Sciences

Red blood cell-derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy

Xiao Han et al.

SCIENCE ADVANCES (2019)

Add to Collection
Review Oncology

Cancer immunoediting and resistance to T cell-based immunotherapy

Jake S. O'Donnell et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Add to Collection
Review Biotechnology & Applied Microbiology

Delivery technologies for cancer immunotherapy

Rachel S. Riley et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Add to Collection
Review Oncology

Improving cancer immunotherapy through nanotechnology

Michael S. Goldberg

NATURE REVIEWS CANCER (2019)

Add to Collection
Review Oncology

Integrative Approaches to Cancer Immunotherapy

Gregory L. Szeto et al.

TRENDS IN CANCER (2019)

Add to Collection
Review Oncology

Tumour heterogeneity and resistance to cancer therapies

Ibiayi Dagogo-Jack et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Add to Collection
Review Cell Biology

RNA-Targeted Therapeutics

Stanley T. Crooke et al.

CELL METABOLISM (2018)

Add to Collection
Review Chemistry, Multidisciplinary

Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment

Samaresh Sau et al.

JOURNAL OF CONTROLLED RELEASE (2018)

Add to Collection
Article Chemistry, Multidisciplinary

Enhanced Cancer Vaccination by In Situ Nanomicelle-Generating Dissolving Microneedles

Nak Won Kim et al.

ACS NANO (2018)

Add to Collection
Review Biochemistry & Molecular Biology

Intra-tumor heterogeneity from a cancer stem cell perspective

Pramudita R. Prasetyanti et al.

MOLECULAR CANCER (2017)

Add to Collection
Review Biochemistry & Molecular Biology

Nano-based delivery of RNAi in cancer therapy

Yong Xin et al.

MOLECULAR CANCER (2017)

Add to Collection
Article Nanoscience & Nanotechnology

Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy

Yuanzeng Min et al.

NATURE NANOTECHNOLOGY (2017)

Add to Collection
Review Oncology

EMT, CSCs, and drug resistance: the mechanistic link and clinical implications

Tsukasa Shibue et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Add to Collection
Review Biotechnology & Applied Microbiology

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

Rajesha Rupaimoole et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Add to Collection
Review Pharmacology & Pharmacy

Drug-Loaded Polymeric Nanoparticles for Cancer Stem Cell Targeting

Binbin Li et al.

FRONTIERS IN PHARMACOLOGY (2017)

Add to Collection
Article Immunology

A melanin-mediated cancer immunotherapy patch

Yanqi Ye et al.

SCIENCE IMMUNOLOGY (2017)

Add to Collection
Review Chemistry, Multidisciplinary

Bridging Bio-Nano Science and Cancer Nanomedicine

Mattias Bjornmalm et al.

ACS NANO (2017)

Add to Collection
Review Immunology

'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations

Eric Tran et al.

NATURE IMMUNOLOGY (2017)

Add to Collection
Review Biochemistry & Molecular Biology

Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future

Nicholas McGranahan et al.

CELL (2017)

Add to Collection
Article Chemistry, Multidisciplinary

Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody

Chao Wang et al.

NANO LETTERS (2016)

Add to Collection
Article Nanoscience & Nanotechnology

Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells

Myung Soo Kim et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)

Add to Collection
Article Chemistry, Multidisciplinary

Microenvironment-Responsive Three-Pronged Approach Breaking Traditional Chemotherapy to Target Cancer Stem Cells for Synergistic Inoperable Large Tumor Therapy

Yan Li et al.

SMALL (2016)

Add to Collection
Review Oncology

Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance

Peyman Ranji et al.

TUMOR BIOLOGY (2016)

Add to Collection
Review Medicine, Research & Experimental

Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics

Lili Zou et al.

THERANOSTICS (2016)

Add to Collection
Article Engineering, Biomedical

Self-Assembling Doxorubicin Prodrug Forming Nanoparticles and Effectively Reversing Drug Resistance In Vitro and In Vivo

Xiaoman Mao et al.

ADVANCED HEALTHCARE MATERIALS (2016)

Add to Collection
Review Pharmacology & Pharmacy

Permeation enhancer strategies in transdermal drug delivery

Harneet Marwah et al.

DRUG DELIVERY (2016)

Add to Collection
Article Chemistry, Multidisciplinary

Chitosan-Decorated Doxorubicin-Encapsulated Nanoparticle Targets and Eliminates Tumor Reinitiating Cancer Stem-like Cells

Wei Rao et al.

ACS NANO (2015)

Add to Collection
Editorial Material Medicine, Research & Experimental

Cancer immunotherapy: harnessing the immune system to battle cancer

Yiping Yang

JOURNAL OF CLINICAL INVESTIGATION (2015)

Add to Collection
Review Chemistry, Multidisciplinary

Exosome mediated communication within the tumor microenvironment

Lara Milane et al.

JOURNAL OF CONTROLLED RELEASE (2015)

Add to Collection
Review Materials Science, Biomaterials

Nanotherapy for Cancer: Targeting and Multifunctionality in the Future of Cancer Therapies

Asiri Ediriwickrema et al.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2015)

Add to Collection
Article Oncology

Doxil Synergizes with Cancer Immunotherapies to Enhance Antitumor Responses in Syngeneic Mouse Models

Jonathan Rios-Doria et al.

NEOPLASIA (2015)

Add to Collection
Review Materials Science, Biomaterials

Nanotherapy for Cancer: Targeting and Multifunctionality in the Future of Cancer Therapies

Asiri Ediriwickrema et al.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2015)

Add to Collection
Review Nanoscience & Nanotechnology

Nanodrugs: pharmacokinetics and safety

Satomi Onoue et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)

Add to Collection
Review Chemistry, Multidisciplinary

PEG-PLGA copolymers: Their structure and structure-influenced drug delivery applications

Keru Zhang et al.

JOURNAL OF CONTROLLED RELEASE (2014)

Add to Collection
Article Biochemical Research Methods

Intracellular autofluorescence: a biomarker for epithelial cancer stem cells

Irene Miranda-Lorenzo et al.

NATURE METHODS (2014)

Add to Collection
Review Oncology

Drug Resistance in Cancer: An Overview

Genevieve Housman et al.

CANCERS (2014)

Add to Collection
Article Chemistry, Multidisciplinary

Bioinspired Exosome-Mimetic Nanovesicles for Targeted Delivery of Chemotherapeutics to Malignant Tumors

Su Chul Jang et al.

ACS NANO (2013)

Add to Collection
Article Biochemistry & Molecular Biology

Self-assembled nucleolipids: from supramolecular structure to soft nucleic acid and drug delivery devices

Vanessa Allain et al.

NUCLEIC ACIDS RESEARCH (2012)

Add to Collection
Review Oncology

Combining immunotherapy and targeted therapies in cancer treatment

Matthew Vanneman et al.

NATURE REVIEWS CANCER (2012)

Add to Collection
Review Multidisciplinary Sciences

Cancer immunotherapy comes of age

Ira Mellman et al.

NATURE (2011)

Add to Collection
Editorial Material Chemistry, Multidisciplinary

Impact of Nanotechnology on Drug Delivery

Omid C. Farokhzad et al.

ACS NANO (2009)

Add to Collection
Review Oncology

Cancer chemoresistance: the relationship between p53 and multidrug transporters

JA Bush et al.

INTERNATIONAL JOURNAL OF CANCER (2002)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.